Loading clinical trials...

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Clostridoides Difficile Infection | Clinical Trials | Clareo Health

WITHDRAWN

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Clostridoides Difficile Infection

NCT04100603•ProgenaBiome

View on ClinicalTrials.gov

Summary

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.

Detailed Description

The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to infection with C. diff.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Willingness to sign informed consent
•Diagnosis of C. difficile infection
•Age of 18 and older

Exclusion Criteria

•Refusal by patient to sign informed consent form
•Treatment with antibiotics 2 weeks prior to screening
•Treatment with probiotics 6 weeks prior to screening
•History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
•Postoperative stoma, ostomy, or ileoanal pouch
•Participation in any experimental drug protocol within the past 12 weeks
•Treatment with total parenteral nutrition
•Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial
•Inability of patient to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire study

Locations (1)

ProgenaBiome

Ventura, California, United States

Key Dates

Start Date

March 2, 2020

Primary Completion Date

March 1, 2030

Completion Date

July 31, 2030

Last Updated

June 5, 2025

Conditions

Clostridium DifficileClostridium Difficile InfectionMicrobiomeCDI

Interventions

No Intervention

OTHER

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

NCT06237452

Clostridium DifficileClostridium Difficile Infections+8 more

View study

RECRUITINGNA

Enhanced Nutritional Optimization in LVAD Trial

NCT05655910

Heart FailureGut Microbiome+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 5, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Clostridoides Difficile Infection

Inclusion Criteria

Exclusion Criteria

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Enhanced Nutritional Optimization in LVAD Trial

Oral Changes With Caloric and no Caloric Sweeteners

The Maggie Project: Exploring the Origin and Heredity of the Vaginal Microbiome

How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types

Effects of Milk-based Drinks on Gut Microbiome, Sleep and Cardiometabolic Markers